These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 10068648)

  • 21. Hydroxyurea enhances fetal hemoglobin production in sickle cell anemia.
    Platt OS; Orkin SH; Dover G; Beardsley GP; Miller B; Nathan DG
    J Clin Invest; 1984 Aug; 74(2):652-6. PubMed ID: 6205021
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A short-term trial of butyrate to stimulate fetal-globin-gene expression in the beta-globin disorders.
    Perrine SP; Ginder GD; Faller DV; Dover GH; Ikuta T; Witkowska HE; Cai SP; Vichinsky EP; Olivieri NF
    N Engl J Med; 1993 Jan; 328(2):81-6. PubMed ID: 7677966
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hydroxyurea: specific therapy for sickle cell anemia?
    Kaufman RE
    Blood; 1992 May; 79(10):2503-6. PubMed ID: 1375102
    [No Abstract]   [Full Text] [Related]  

  • 24. Sickle cell anemia: targeting the role of fetal hemoglobin in therapy.
    Coleman E; Inusa B
    Clin Pediatr (Phila); 2007 Jun; 46(5):386-91. PubMed ID: 17556734
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Spectrum of fetal hemoglobin responses in sickle cell patients treated with hydroxyurea: the National Institutes of Health experience.
    Rodgers GP
    Semin Oncol; 1992 Jun; 19(3 Suppl 9):67-73. PubMed ID: 1379375
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hydroxyurea for sickle cell anemia.
    Naina HV; Harris S
    N Engl J Med; 2008 Jul; 359(1):98; author reply 98-9. PubMed ID: 18596283
    [No Abstract]   [Full Text] [Related]  

  • 27. Progress toward increasing fetal hemoglobin production in man: experience with 5-azacytidine and hydroxyurea.
    Dover GJ; Charache S; Nora R; Boyer SH
    Ann N Y Acad Sci; 1985; 445():218-24. PubMed ID: 2409873
    [No Abstract]   [Full Text] [Related]  

  • 28. Chemotherapy and hemoglobin F synthesis in sickle cell disease.
    Dover GJ; Charache S
    Ann N Y Acad Sci; 1989; 565():222-7. PubMed ID: 2476061
    [No Abstract]   [Full Text] [Related]  

  • 29. Pharmacologic manipulation of fetal hemoglobin. Update on clinical trials with hydroxyurea.
    Dover GJ
    Ann N Y Acad Sci; 1990; 612():184-90. PubMed ID: 1705407
    [No Abstract]   [Full Text] [Related]  

  • 30. Effect of hydroxyurea on G gamma chain fetal hemoglobin synthesis by sickle-cell disease patients.
    Teixeira SM; Cortellazzi LC; Grotto HZ
    Braz J Med Biol Res; 2003 Oct; 36(10):1289-92. PubMed ID: 14502358
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hydroxyurea and sickle cell disease: a chance for every patient.
    Weiner DL; Brugnara C
    JAMA; 2003 Apr; 289(13):1692-4. PubMed ID: 12672739
    [No Abstract]   [Full Text] [Related]  

  • 32. Pharmacologic stimulation of Hb F in patients with sickle cell anemia.
    Galanello R; Veith R; Papayannopoulou T; Stamatoyannopoulos G
    Prog Clin Biol Res; 1985; 191():433-45. PubMed ID: 2413479
    [No Abstract]   [Full Text] [Related]  

  • 33. Hydroxyurea, sickle cell disease and renal transplantation.
    Allen A; Scoble J; Snowden S; Hambley H; Bellingham A
    Nephron; 1997; 75(1):106-7. PubMed ID: 9031282
    [No Abstract]   [Full Text] [Related]  

  • 34. [Hydroxyurea and other agents stimulating synthesis of fetal hemoglobin].
    de Montalembert M
    Pathol Biol (Paris); 1999 Jan; 47(1):55-8. PubMed ID: 10081780
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term use of hydroxyurea for sickle cell anemia.
    Hagar W
    JAMA; 2003 Aug; 290(6):753; author reply 754. PubMed ID: 12915424
    [No Abstract]   [Full Text] [Related]  

  • 36. Hydroxyurea-induced augmentation of fetal hemoglobin production in patients with sickle cell anemia.
    Charache S; Dover GJ; Moyer MA; Moore JW
    Blood; 1987 Jan; 69(1):109-16. PubMed ID: 2431728
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of hydroxyurea on fetal hemoglobin production in vitro.
    Miller BA; Platt O; Hope S; Dover G; Nathan DG
    Blood; 1987 Dec; 70(6):1824-9. PubMed ID: 2445401
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacological induction of fetal hemoglobin synthesis using histone deacetylase inhibitors.
    Cao H
    Hematology; 2004 Jun; 9(3):223-33. PubMed ID: 15204104
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of fetal hemoglobin synthesis in the hemoglobinopathies.
    Nathan DG
    Ann N Y Acad Sci; 1985; 445():177-87. PubMed ID: 2409870
    [No Abstract]   [Full Text] [Related]  

  • 40. Valproic acid and augmentation of fetal hemoglobin in individuals with and without sickle cell disease.
    Selby R; Nisbet-Brown E; Basran RK; Chang L; Olivieri NF
    Blood; 1997 Jul; 90(2):891-3. PubMed ID: 9226193
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.